Friday, May 1, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

CDC & DOJ: A Forbidden Love Affair

Daily Remedy by Daily Remedy
May 1, 2022
in Politics & Law
0
CDC & DOJ: A Forbidden Love Affair

The CDC and DOJ make for curious bedfellows. Ostensibly, they are different organizations. One is a national health agency under the Department of Health and Human Services (DHHS). The other enforces federal laws set forth by Congress.

Few would imagine healthcare and law have much in common. But few would have imagined such a pandemic in today’s world. Suddenly, personal health became public policy and individual health choices became legal mandates. Health and law blended in ways few could have predicted.

“It’s just, I think, important for me to explain the role of the Justice Department, which is not to make judgments about public health, but rather to make determinations of whether the programs and requests of the agencies that are responsible for those are lawful,” Attorney General Merrick Garland told Senator Susan Collins, a Republican from Maine, when discussing mask mandates.

But what is a law if not a judgment on individual behavior? If someone knows the speed limit and drives in excess of it regardless, is that person not making a judgment on whether to obey the law?

The linguistic gymnastics we see from policy makers of late belies an uncomfortable reality – the CDC and the DOJ parlay the resources of each respective organization to set forth and enforce public health policies as de facto laws. This is the root of their intimacy. And attempts to differentiate each department’s role by parsing the difference between policy and law in vague terms is nothing more than privately rehearsed pillow talk passing as rhetoric for public talking points.

As with most things health policy related, the pandemic made apparent what was always present in the federal government. In fact, this curious relationship between the CDC and DOJ began nearly a decade ago, during President Obama’s administration – at the beginning of the hysteria surrounding the opioid epidemic.

It was then we first heard cries about the opioid epidemic that have now become familiar. President Obama’s administration began driving massive funds toward federal organizations enacting and implementing policies designed to curb the opioid epidemic – including the CDC and the DOJ – as though the two had equal parts to play in combating it.

Out of those funds, the DHHS initiated the Strategic Prevention Framework for Prescription Drugs, which eventually led to the 2016 CDC opioid prescribing guidelines.

At the same time, the DOJ, along with 49 state attorney generals, established Prescription Drug Monitoring Programs (PDMPs) to help prescribers identify potential opioid misuse issues.

Today, law enforcement agencies monitor data from PDMPs using the 2016 prescription opioid guidelines to gauge which prescribers are deemed high risk. It is openly acknowledged that the CDC and DOJ collaborate toward one coherent public health policy when it comes to opioids, even if neither admits as much.

One uses the court of law to enforce policies set forth by the other, advancing like pieces in a chess move gambit.

Now, we have the CDC openly advocating the DOJ to enforce its policies and the DOJ actively participating in public health policy set by the CDC.

The manner in which the CDC and DOJ continue to collaborate over the opioid epidemic provides insight into how the two organizations have collaborated over pandemic related issues, particularly mask mandates. And will continue as long as the pandemic lingers. But eventually the pandemic has to subside – whether that is in a few weeks or a few months.

What remains to be seen is how the relationship will disentangle – or whether it will at all. The opioid epidemic and the COVID pandemic introduced unique societal problems, prompting a bizarre relationship between health policy and law enforcement through a series of government initiatives.

That with regard to actual clinical outcomes has produced mix results at best. The opioid epidemic continues to rage, even worsening during the pandemic. Public trust in the CDC is now at historical lows. Physicians actively question CDC decision-making with their patients. We see every CDC policy through the lens of its unintended effects instead of its actual policy implication.

Perhaps what we need is less collaboration and more Federalism; less intimacy and more clearly defined initiatives that provide a much needed separation between these departments.

Laws define clear parameters around well-established behavior. Polices guide behavior in situations where ambiguity exists. How we can turn health policies into laws when the pandemic is ambiguity incarnate? Even the DOJ acknowledges it struggles to understand what is truly legal.

But power by nature rarely cedes itself. When confronted with limitations, the CDC, instead of acknowledging what it does not know, simply finds the means to enforce what it believes to be true – assuming what it knows to be all that there is to know – or phrased more succinctly, CDC policy ergo DOJ law.

Which may make for a good relationship between the two departments, but it makes for bad policy and even worse law.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 0

  1. Pingback: » CDC & DOJ: A Forbidden Love Affair PHARMACIST STEVE

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • A doctor tapping a tablet near a window in their office during the daytime. The doctor smiles at the tablet.

    The Importance of Access Control in the Workplace

    0 shares
    Share 0 Tweet 0
  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • Detecting Hospital M&A Synergies Before They’re Announced: A Rate-Based Event Strategy

    0 shares
    Share 0 Tweet 0
  • State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy